【目的】观察采用静脉镇痛泵、琥珀酸索利那新片、酒石酸托特罗定缓释片联合静脉镇痛泵治疗经尿道前列腺电切术（TURP）后膀胱痉挛的疗效。【方法】将本院80例行TURP术后患者随机均分为四组。对照组于膀胱痉挛出现后给予哌替啶50 mg联...【目的】观察采用静脉镇痛泵、琥珀酸索利那新片、酒石酸托特罗定缓释片联合静脉镇痛泵治疗经尿道前列腺电切术（TURP）后膀胱痉挛的疗效。【方法】将本院80例行TURP术后患者随机均分为四组。对照组于膀胱痉挛出现后给予哌替啶50 mg联合山莨菪碱10 mg 肌肉注射。静脉镇痛泵组手术后患者保留静脉镇痛泵导管，连接静脉输液（镇痛液配方为舒芬太尼100μg＋格拉司琼6 mg ，用生理盐水稀释至100 mL ），调节药量为恒速注药2mL，维持72h。索利那新组手术前1d口服琥珀酸索利那新片每次5mg，1次/日；联合用药组手术前1d口服酒石酸托特罗定缓释片每次2mg ，1次/日，同时联合静脉镇痛泵治疗。比较各组临床疗效。【结果】试验三组术后d1，d2，d3膀胱痉挛次数、膀胱痉挛平均持续时间、膀胱冲洗液转清时间均短于对照组，联合用药组的膀胱痉挛次数及膀胱痉挛平均持续时间均短于静脉镇痛泵组及索利那新组，且各组之间比较差异均有显著性（均 P ＜0．05），静脉镇痛泵组及索利那新组各项指标相比较差异无显著性（ P ＞0．05）。【结论】静脉镇痛泵、琥珀酸索利那新片、酒石酸托特罗定缓释片联合静脉镇痛泵三种方式对于预防和治疗术T U RP后早期膀胱痉挛均有较好的效果，且联合用药组效果更加显著，可在临床推广。展开更多
AIM:To investigate all patients referred to our center with non-responsive celiac disease (NRCD),to establish a cause for their continued symptoms.METHODS:We assessed all patients referred to our center with non-respo...AIM:To investigate all patients referred to our center with non-responsive celiac disease (NRCD),to establish a cause for their continued symptoms.METHODS:We assessed all patients referred to our center with non-responsive celiac disease over an 18-mo period.These individuals were investigated to establish the eitiology of their continued symptoms.The patients were first seen in clinic where a thorough history and examination were performed with routine blood work including tissue transglutaminase antibody measurement.They were also referred to a specialist gastroenterology dietician to try to identift any lapses in the diet and sources of hidden gluten ingestion.A repeat small intestinal biopsy was also performed and compared to biopsies from the referring hospital where possible.Colonoscopy,lactulose hydrogen breath testing,pancreolauryl testing and computed tomography scan of the abdomen were undertaken if the symptoms persisted.Their clinical progress was followed over a minimum of 2 years.RESULTS:One hundred and twelve consecutive patients were referred with NRCD.Twelve were found not to have celiac disease (CD).Of the remaining 100 patients,45% were not adequately adhering to a strict gluten-free diet,with 24 (53%) found to be inadvertently ingesting gluten,and 21 (47%) admitting noncompliance.Microscopic colitis was diagnosed in 12% and small bowel bacterial overgrowth in 9%.Refractory CD was diagnosed in 9%.Three of these were diagnosed with intestinal lymphoma.After 2 years,78 patients remained well,eight had continuing symptoms,and four had died.CONCLUSION:In individuals with NRCD,a remediable cause can be found in 90%:with continued gluten ingestion as the leading cause.We propose an algorithm for investigation.展开更多
文摘【目的】观察采用静脉镇痛泵、琥珀酸索利那新片、酒石酸托特罗定缓释片联合静脉镇痛泵治疗经尿道前列腺电切术（TURP）后膀胱痉挛的疗效。【方法】将本院80例行TURP术后患者随机均分为四组。对照组于膀胱痉挛出现后给予哌替啶50 mg联合山莨菪碱10 mg 肌肉注射。静脉镇痛泵组手术后患者保留静脉镇痛泵导管，连接静脉输液（镇痛液配方为舒芬太尼100μg＋格拉司琼6 mg ，用生理盐水稀释至100 mL ），调节药量为恒速注药2mL，维持72h。索利那新组手术前1d口服琥珀酸索利那新片每次5mg，1次/日；联合用药组手术前1d口服酒石酸托特罗定缓释片每次2mg ，1次/日，同时联合静脉镇痛泵治疗。比较各组临床疗效。【结果】试验三组术后d1，d2，d3膀胱痉挛次数、膀胱痉挛平均持续时间、膀胱冲洗液转清时间均短于对照组，联合用药组的膀胱痉挛次数及膀胱痉挛平均持续时间均短于静脉镇痛泵组及索利那新组，且各组之间比较差异均有显著性（均 P ＜0．05），静脉镇痛泵组及索利那新组各项指标相比较差异无显著性（ P ＞0．05）。【结论】静脉镇痛泵、琥珀酸索利那新片、酒石酸托特罗定缓释片联合静脉镇痛泵三种方式对于预防和治疗术T U RP后早期膀胱痉挛均有较好的效果，且联合用药组效果更加显著，可在临床推广。
文摘AIM:To investigate all patients referred to our center with non-responsive celiac disease (NRCD),to establish a cause for their continued symptoms.METHODS:We assessed all patients referred to our center with non-responsive celiac disease over an 18-mo period.These individuals were investigated to establish the eitiology of their continued symptoms.The patients were first seen in clinic where a thorough history and examination were performed with routine blood work including tissue transglutaminase antibody measurement.They were also referred to a specialist gastroenterology dietician to try to identift any lapses in the diet and sources of hidden gluten ingestion.A repeat small intestinal biopsy was also performed and compared to biopsies from the referring hospital where possible.Colonoscopy,lactulose hydrogen breath testing,pancreolauryl testing and computed tomography scan of the abdomen were undertaken if the symptoms persisted.Their clinical progress was followed over a minimum of 2 years.RESULTS:One hundred and twelve consecutive patients were referred with NRCD.Twelve were found not to have celiac disease (CD).Of the remaining 100 patients,45% were not adequately adhering to a strict gluten-free diet,with 24 (53%) found to be inadvertently ingesting gluten,and 21 (47%) admitting noncompliance.Microscopic colitis was diagnosed in 12% and small bowel bacterial overgrowth in 9%.Refractory CD was diagnosed in 9%.Three of these were diagnosed with intestinal lymphoma.After 2 years,78 patients remained well,eight had continuing symptoms,and four had died.CONCLUSION:In individuals with NRCD,a remediable cause can be found in 90%:with continued gluten ingestion as the leading cause.We propose an algorithm for investigation.
